Stronger Together: Riley Children’s Health joins CureWorks collaborative
Riley Children’s Health at Indiana University Health is proud to become the only CureWorks member hospital in the Midwest. This unique collaboration will allow Riley oncologists and Indiana University School of Medicine researchers greater access to cutting-edge immunotherapy trials for pediatric oncology patients.
This elite network of children’s hospitals knows we are stronger together. So, by connecting five academic children’s hospitals – from Seattle to Washington D.C. – patients get more advanced, more convenient care.
Member hospitals are supported in launching and participating in exclusive clinical trials. CureWorks streamlines immunotherapy production, clinical trial enrollment and the trial coordination process.
“This opportunity to work with esteemed partners will allow more rapid development of the new frontier of care to help children fight cancer,” said Riley Children’s Health chief medical officer Dr. Elaine Cox, “Together we can make a difference – faster.”
Riley Children’s Health is a Midwest destination for pediatric and adolescent/young adult cancer care as the number 15 ranked pediatric oncology program in the country (U.S. News & World Report).
“We are thrilled that Riley Children’s Health at Indiana University Health is joining CureWorks to be a key part of our collaborative effort to accelerate the discovery of new therapies for pediatric cancer,” said Dr. Michael Jensen, executive director of CureWorks and director of the Ben Towne Center for Childhood Cancer Research at Seattle Children's Research Institute. “Through this collaboration and by extending the reach of promising clinical trials, our goal is to more quickly develop treatments with fewer side effects, better remission rates and, ultimately, enable more kids with cancer to grow up and realize their full potential.”